Cytochromes P450 and cancer

Mol Aspects Med. Feb-Apr 1999;20(1-2):70-84, 137.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / metabolism*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Aryl Hydrocarbon Hydroxylases*
  • Cytochrome P-450 CYP1A1 / genetics
  • Cytochrome P-450 CYP1A1 / metabolism
  • Cytochrome P-450 CYP1B1
  • Cytochrome P-450 CYP2D6 / genetics
  • Cytochrome P-450 CYP2D6 / metabolism
  • Cytochrome P-450 CYP2E1 / genetics
  • Cytochrome P-450 CYP2E1 / metabolism
  • Cytochrome P-450 Enzyme System / drug effects
  • Cytochrome P-450 Enzyme System / genetics*
  • Cytochrome P-450 Enzyme System / metabolism*
  • Genetic Predisposition to Disease
  • Genetic Therapy
  • Humans
  • Lung Neoplasms / chemically induced
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / therapy*
  • Polymorphism, Genetic
  • Xenobiotics / metabolism

Substances

  • Antineoplastic Agents
  • Xenobiotics
  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP2E1
  • Aryl Hydrocarbon Hydroxylases
  • CYP1B1 protein, human
  • Cytochrome P-450 CYP1A1
  • Cytochrome P-450 CYP1B1
  • Cytochrome P-450 CYP2D6